This study aims to evaluate the eye care benefits of anti-aging compound capsules in healthy adults. Participants will consume anti-aging compound capsules containing botanical extracts, omega-3 fatty acids, vitamins, minerals, and hyaluronic acid for four weeks. The primary outcome is the improvement of ocular discomfort and eye fatigue symptoms assessed using the Ocular Surface Disease Index (OSDI). Secondary outcomes include visual acuity, accommodative function, tear film stability, macular pigment optical density, intraocular pressure, and photostress recovery time. The study will investigate whether daily supplementation with anti-aging compound capsules can improve visual comfort and support ocular health.
Age range
20 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in Ocular Surface Disease Index (OSDI) Score
Timeframe: baseline / week2 / week4
Change in Distance Visual Acuity (DVA, logMAR)
Timeframe: baseline / week2 / week4
Change in Near Visual Acuity (NVA)
Timeframe: baseline / week2 / week4
Change in Accommodative Response
Timeframe: baseline / week2 / week4
Change in Accommodative Facility (cycles per minute)
Timeframe: baseline / week2 / week4
Change in Tear Film Break-Up Time (TBUT)
Timeframe: baseline / week2 / week4
Change in Macular Pigment Optical Density (MPOD)
Timeframe: baseline / week2 / week4
Change in Photostress Recovery Time
Timeframe: baseline / week2 / week4